Anuj Verma, MBBS, MD
Clinical Fellow
Research & Publications
Biography
Coauthors
Selected Publications
- New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasisKhanduri I, Maki H, Verma A, Katkhuda R, Anandappa G, Pandurengan R, Zhang S, Mejia A, Tong Z, Solis Soto L, Jadhav A, Wistuba I, Menter D, Kopetz S, Parra E, Vauthey J, Maru D. New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis. BJC Reports 2024, 2: 37. DOI: 10.1038/s44276-024-00056-8.
- Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective studyde Sousa L, Liu S, Bhosale P, Altan M, Darbonne W, Schulze K, Dervin S, Yun C, Mahvash A, Verma A, Futreal A, Gite S, Cuentas E, Cho W, Wistuba I, Yao J, Woodman S, Halperin D, Ferrarotto R. Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study. Oral Oncology 2024, 151: 106747. PMID: 38460288, DOI: 10.1016/j.oraloncology.2024.106747.
- A case of spuriously low serum creatinine concentrations in a patient with acetaminophen poisoningVerma A, Figueroa Villalba C, Choucair I, El-Khoury JM. A case of spuriously low serum creatinine concentrations in a patient with acetaminophen poisoning. Clinica Chimica Acta 2022, 535: 195-196. PMID: 36075459, DOI: 10.1016/j.cca.2022.09.001.
- Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)Johnson B, Haymaker C, Parra E, Soto L, Wang X, Thomas J, Dasari A, Morris V, Raghav K, Vilar E, Kee B, Eng C, Parseghian C, Wolff R, Lee Y, Lorenzini D, Laberiano-Fernandez C, Verma A, Lang W, Wistuba I, Futreal A, Kopetz S, Overman M. Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Journal For ImmunoTherapy Of Cancer 2022, 10: e005332. PMID: 36007963, PMCID: PMC9422817, DOI: 10.1136/jitc-2022-005332.
- Emerging Immunohistochemical Biomarkers for Myeloid Neoplasms.Verma A, Xu ML. Emerging Immunohistochemical Biomarkers for Myeloid Neoplasms. Archives Of Pathology & Laboratory Medicine 2022, 147: 403-412. PMID: 35533352, DOI: 10.5858/arpa.2021-0558-ra.
- An analysis of research biopsy core variability from over 5000 prospectively collected core samplesBhamidipati D, Verma A, Sui D, Maru D, Mathew G, Lang W, Posadas J, Hein J, Kopetz S, Futreal A, Wistuba I, Gupta S, Lee J, Overman M, Tam A. An analysis of research biopsy core variability from over 5000 prospectively collected core samples. Npj Precision Oncology 2021, 5: 94. PMID: 34707215, PMCID: PMC8551285, DOI: 10.1038/s41698-021-00234-8.
- ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal CancerSarshekeh A, Alshenaifi J, Roszik J, Manyam G, Advani S, Katkhuda R, Verma A, Lam M, Willis J, Shen J, Morris J, Davis J, Loree J, Lee H, Ajani J, Maru D, Overman M, Kopetz S. ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical Cancer Research 2021, 27: 1663-1670. PMID: 33414133, PMCID: PMC7956157, DOI: 10.1158/1078-0432.ccr-20-2404.
- Chagas disease initially diagnosed in a lymph node.Verma A, Pan Z. Chagas disease initially diagnosed in a lymph node. Blood 2020, 136: 2478. PMID: 33211840, DOI: 10.1182/blood.2020008815.
- Abstract 808: Analysis of 1151 prospective research biopsies: Factors influencing tumor yield across patients and biopsy coresBhamidipati D, Verma A, Maru D, Sui D, Mathew G, Lang W, Posadas J, Hein J, Kopetz S, Futreal A, Wistuba I, Lee J, Overman M, Tam A. Abstract 808: Analysis of 1151 prospective research biopsies: Factors influencing tumor yield across patients and biopsy cores. Cancer Research 2020, 80: 808-808. DOI: 10.1158/1538-7445.am2020-808.
- Abstract B06: A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveriesVeeranki O, Tong Z, Mejia A, Verma A, Katkhuda R, Bassett R, Kim T, Wang J, Lang W, Mino B, Solis L, Kingsley C, Norton W, Tailor R, Wu J, Krishnan S, Lin S, Blum M, Hofstetter W, Ajani J, Kopetz S, Maru D. Abstract B06: A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries. Cancer Research 2020, 80: b06-b06. DOI: 10.1158/1538-7445.camodels2020-b06.
- Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinomaTong Z, Mejia A, Veeranki O, Verma A, Correa A, Patel V, Dokey R, Solis L, Mino B, Kathkuda R, Canales J, Lin S, Krishnan S, Kopetz S, Blum M, Ajani J, Hofstetter W, Maru D. Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. 2019, 3859-3859. DOI: 10.1158/1538-7445.sabcs18-3859.
- Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinomaTong Z, Mejia A, Veeranki O, Verma A, Correa A, Patel V, Dokey R, Solis L, Mino B, Kathkuda R, Canales J, Lin S, Krishnan S, Kopetz S, Blum M, Ajani J, Hofstetter W, Maru D. Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Cancer Research 2019, 79: 3859-3859. DOI: 10.1158/1538-7445.am2019-3859.
- Association of TGF-β expression with intratumoral infiltration of cytotoxic T lymphocytes in patients with microsatellite-stable colorectal cancer.Mehrvarz Sarshekeh A, Katkhuda R, Verma A, Advani S, Overman M, Maru D, Kopetz S. Association of TGF-β expression with intratumoral infiltration of cytotoxic T lymphocytes in patients with microsatellite-stable colorectal cancer. Journal Of Clinical Oncology 2019, 37: 3577-3577. DOI: 10.1200/jco.2019.37.15_suppl.3577.